6 August, Perspectum Group, offering medical imaging software, withdrew the application for IPO. The company planned to attract 75 million dollars, releasing 4,7 million shares at a price from 15 to 17 Dollars.
6 August biotech company Pasithea Therapeutics, investigating drugs for the treatment of psychiatric and nervous disorders, in the preclinical stage of research, announced the terms of the upcoming IPO.
6 August private mortgage insurance company Enact Holdings, separated from Genworth Financial, reapplied for IPO, after postponing the placement in May for 497 million dollars. In its latest filing, the company released financial results for 1 Half 2021 of the year.
9 August authID.ai, offering a platform for biometric identity verification, announced the revision of the terms of the upcoming IPO. Now headquartered in Long Beach, New York State, plans to attract 20 million dollars, releasing 2,1 mln shares at the closing price on OTCQB (AUID) on 3 august, equal 9,63 Dollars.
For young innovative companies, who have successfully approached the stage of IPO, enriching the investors who believed in them, the special term "unicorns" was coined - they were so rare. The term "unicorn" was first used by venture capitalist Eileen Lee in 2013 G.
2020 the year was difficult for market participants. He then fell under the pressure of panic, then took off on a wave of euphoria. About five million new investors came to the exchange, creating a favorable background for IPOs (IPO)
Ticker: HOOD Financial Services Platform. to 27.07.2021 20:00 [MSC] Revenue 2019: 277,5m | 2020: 958,8m | 245.5% 20Q1: 127,6m | 21Q1: 522,2m | 309.4% Profit While losses Express withdrawal Good growth in accelerating revenue. Debts 1.
Ticker: TEAD Advertising Aggregator for Advertisers, agencies and publishers. to 28.07.2021 20:00 [MSC] Revenue 2019: 509,5m | 2020: 540,3m | 6% 20Q1: 95,6m | 21Q1: 126,6m | 32.5% Profit 2019: 55,3m | 2020: 111,5m | 101.8% 20Q1: -1,0m | 21Q1: 28,0m Express withdrawal Weak growth, but accelerating revenue. Excellent profit growth. Debts 0.
IPO, that don't pass my primary participation filter, now I will not analyze, I will save time. Let me remind you the filter: US company capitalization >$3Availability of proceeds Freedom Finance approved 3 more IPOs this week: RxSight (RXST)Capitalization: $447m Omega Therapeutics (OMGA)
We have seen a decline in Chinese stocks in recent weeks, and the question arises: is it profitable to invest in them now? Shares of Chinese companies Shares of Chinese companies It would seem, the cheaper the shares become, all the better: you can buy more shares for one amount and the growth potential will be greater.